Related Experiment Video
Updated: Oct 5, 2025
High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
Published on: September 23, 2014
Differentiation and Characterization of Human Pluripotent Stem Cell-Derived Cardiac Endothelial Cells for In Vitro
Kavita Raniga1, Nguyen T N Vo1, Chris Denning2
1Department of Stem Cell Biology, Biodiscovery Institute, University of Nottingham, Nottingham, UK.
Insights
This study presents a new protocol for generating cardiac endothelial cells (CECs) from human pluripotent stem cells (hPSCs) without cell sorting. This method enhances reproducibility for cardiac research and disease modeling.
Area of Science:
- Cardiovascular Biology
- Stem Cell Biology
- Cellular Differentiation
Background:
- Generating pure endothelial cell (EC) populations for research often requires complex cell sorting.
- Existing protocols yield heterogeneous ECs, complicating their use in disease modeling and regenerative medicine.
- Specific EC subtypes possess unique molecular signatures crucial for accurate model systems.
Purpose of the Study:
- To develop a reproducible protocol for cardiac EC differentiation from human induced pluripotent stem cells (hiPSCs).
- To establish methods for characterizing differentiated cardiac ECs using endothelial lineage markers.
- To eliminate the need for cell sorting in generating functional cardiac ECs.
Main Methods:
- Developed a specific protocol for cardiac EC differentiation from hiPSCs.
- Utilized flow cytometry to measure key endothelial markers: CD31, VE-Cadherin, and VEGFR2.
- Validated the protocol across different hiPSC lines to ensure reproducibility.
Main Results:
- Achieved efficient and reproducible differentiation of cardiac ECs without cell sorting.
- Demonstrated successful characterization of differentiated ECs using standard endothelial markers.
- The protocol provides a reliable method for generating cardiac ECs from various hiPSC lines.
Conclusions:
- The described protocol enables efficient, reproducible generation of cardiac ECs from hiPSCs, bypassing the need for cell sorting.
- This method enhances the utility of hiPSCs for cardiac disease modeling, drug screening, and regenerative applications.
- The protocol is adaptable for generating other cardiovascular cell types, supporting complex cardiovascular model development.
Abstract:
Various protocols have been developed to generate endothelial cells for disease modeling, angiogenesis, vascular regeneration, and drug screening. These protocols often require cell sorting, as most differentiation strategies result in a heterogenous population of endothelial cells (ECs). For any given model system, one important consideration is choosing the appropriate EC subtype, as different EC populations have unique molecular signatures.Herein, we describe a protocol for cardiac EC differentiation and a protocol for endothelial cell characterization. This protocol is aimed at investigating differentiation efficiency by measuring endothelial lineage markers, CD31, VE-Cadherin, and VEGFR2 by flow cytometry. Collectively, these protocols comprise the tools required to generate cardiac ECs efficiently and reproducibly from different hPSC lines without the need for cell sorting. Our protocol adds to the panel of hPSCs for cardiac EC differentiation and addresses reproducibility concerns of hPSC-based experiments. The approaches described are also applicable for complex model generation where multiple cardiovascular cell types are involved and may assist in optimizing differentiations for different cell lineages, including cardiomyocytes, cardiac endothelial cells, and cardiac fibroblasts.
